Antibody against oxidized LDL/β2GPI complex and use of the same
US8575314B2 · kind B2 · utility
5Cited by
26References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 9, 2009 |
| Grant date | Nov 5, 2013 |
| Priority date | — |
| Expiry date | May 15, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/323
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
From antibodies that can be used to immunostain atherosclerotic tissue sections, the present inventors selected antibodies applicable to in vivo imaging, and analyzed their specificities. The result showed that fluorescently labeled anti-oxidized LDL/β2GPI complex antibodies that are specific to a particular epitope were effective for imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.